M8

TEVA PHARMACEUTICAL INDS LTD

M8769Q102
Q3 2026 funds231 buying0 selling

TEVA PHARMACEUTICAL INDS LTD institutional ownership changes in Q3 2026: 231 institutions opened or added positions, 0 trimmed or exited. M8769Q102 (TEVA PHARMACEUTICAL INDS LTD) is held by 231 institutional investors as of Q3 2026. Top institutional shareholders: Bank of Montreal ($4.5B), BlackRock, Inc. ($2.5B), Phoenix Financial Ltd. ($1.7B). Institutions were buying, on balance.

Top Holders

Fund ownership
Fund holdings as of
Funds holding231
avg9 elite funds
Value of reported holdings$23.4B
Funds buying / selling
231opened or added
0reduced or exited
100% buying consensus
Checking access…
Action
New
1.1M$4.5B1.4%—
73
New
63.4M$2.5B0.0%—
44
New
42.6M$1.7B11.4%—
98
New
42.3M$1.7B2.8%—
83
New
32.5M$1.3B0.0%—
44
New
25.8M$1B0.0%—
44
New
19.3M$764.6M0.0%—
44
New
18M$713.1M0.1%—
44
New
11.9M$470.4M0.0%—
43
New
11.6M$458.4M4.3%—
87
New
10.5M$415.4M0.1%—
43
New
9.3M$369.7M0.0%—
43
New
7.6M$299.6M4.9%—
86
New
7.4M$291.3M0.0%—
43
New
7.2M$283.9M0.0%—
43
New
6.3M$250.3M0.1%—
43
New
6.1M$242.3M0.8%—
60
New
5.9M$234.3M0.0%—
42
New
480$234M3.7%—
85
New
5.8M$229.9M0.6%—
60

Showing 1-20 of 231

1 / 12
Loading insider trades…
Loading Congress trades…
Loading activist filings…

Questions investors ask about M8769Q102

Who owns TEVA PHARMACEUTICAL INDS LTD?

231 institutional investors held TEVA PHARMACEUTICAL INDS LTD on September 30, 2026, led by Bank of Montreal ($4.5B), BlackRock, Inc. ($2.5B) and Phoenix Financial Ltd. ($1.7B).

How many hedge funds hold TEVA PHARMACEUTICAL INDS LTD?

231 institutional investors reported TEVA PHARMACEUTICAL INDS LTD in their 13F filings for the quarter ended September 30, 2026, $23.4B in all. 9 of them are rated Elite.

Are institutions buying or selling TEVA PHARMACEUTICAL INDS LTD?

Buying, on balance. In Q3 2026, 231 institutions opened or added to positions in TEVA PHARMACEUTICAL INDS LTD and 0 institutions trimmed or exited.

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Optional analytics helps us improve. How it’s used